2018 update of the EULAR recommendations for the management of Behçet's syndromeGülen Hatemi, Hasan Yazıcı, Robin Christensen et al.|Annals of the Rheumatic Diseases|2018Cited by 771
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trialFrances Humby, Raquel Celis, Hasan Rizvi et al.|The Lancet|2021Cited by 315